Publications

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Open

Perceptions and recommendations of physicians/KOLs on value added medicines

21 November 2019

Report

Open

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Open

A digital future for value added medicines

24 September 2019

Policy, Report

Open

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Open

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Open

Value Added Medicines: Time to Adjust the HTA Decision Frameworks

5 September 2017

Report

Open

Global Healthcare Trends and Outlook

15 June 2017

Report

Open

ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Read more

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

Open

Subscribe to our newsletter